Results 11 to 20 of about 673 (120)
Percutaneous radiofrequency ablation on a Xp11.2 Translocation Renal Cell Carcinoma: A case report [PDF]
Urology Case Reports, 2020 Xp11.2 Translocation Renal Cell Carcinoma is a very rare subtype of renal neoplasm. The present report describes the first confirmed reported case of percutaneous ablation of this subtype of tumor.
Alexandre Fligelman Kanas +5 more
doaj +2 more sources
Surgical management of giant Xp11.2 translocation renal cell carcinoma with multivisceral invasion: a case report of en bloc resection and targeted-immunotherapy success [PDF]
Frontiers in OncologyA 36-year-old man presented with a 1-month history of abdominal distension and a 3-day palpable mass. Imaging demonstrated a 20-cm left renal tumor with adjacent organ infiltration and suspicious lymphadenopathy, radiologically suggestive of sarcoma or ...
Bohan Luo, Han Luo
doaj +2 more sources
ANGPTL2‐mediated epigenetic repression of MHC‐I in tumor cells accelerates tumor immune evasion
Molecular Oncology, 2023 Loss or downregulation of major histocompatibility complex class I (MHC‐I) contributes to tumor immune evasion. We previously demonstrated that angiopoietin‐like protein 2 (ANGPTL2) promotes tumor progression using a Xp11.2 translocation renal cell ...
Tsuyoshi Kadomatsu +13 more
doaj +2 more sources
Rare Tumors, 2009 Xp11.2 translocation renal cell carcinomas (TRCCs) are a rare family of tumors newly recognized by the World Health Organization (WHO) in 2004. These tumors result in the fusion of partner genes to the TFE3 gene located on Xp11.2. They are most common in
James Brown +3 more
doaj +3 more sources
Computational analysis of pathological images enables a better diagnosis of TFE3 Xp11.2 translocation renal cell carcinoma [PDF]
Nature Communications, 2020 Translocation renal cell carcinoma is an aggressive form of renal cancer that is often misdiagnosed to other subtypes. Here the authors demonstrated that by using machine learning and H&E stained whole-slide images, an accurate diagnose of this ...
Jun Cheng +9 more
doaj +2 more sources
PD-L1 expression in Xp11.2 translocation renal cell carcinoma: Indicator of tumor aggressiveness [PDF]
Scientific Reports, 2017 Programmed death ligand-1 (PD-L1), a promising antitumor target, has proven clinical value against many malignancies. However, the PD-L1 content of Xp11.2 translocation renal cell carcinoma (Xp11.2 RCC) and its correlation with clinical outcomes remain ...
Kun Chang +10 more
doaj +2 more sources
Robot-assisted partial nephrectomy for TFE3-rearranged renal cell carcinoma: a case report and literature review [PDF]
Frontiers in OncologyBackgroundTFE3-rearranged renal cell carcinoma (TFE3-RCC) is a rare RCC subtype driven by translocation involving Xp11.2 and TFE3 gene fusion. The management of TFE3-RCC is similar to that of other RCC subtypes and primarily involves surgical resection ...
Biao Jiang +3 more
doaj +2 more sources
BMC Urology, 2022 Purpose To report the clinicopathological features and mid- to long-term oncologic results of Xp11.2 translocation/transcription factor E3 (TFE3) gene fusion renal cell carcinomas (Xp11.2 translocation RCCs) in a single large-volume centrecentre. Methods
Jiale Zhou +5 more
doaj +1 more source
Frontiers in Pediatrics, 2023 RCC accounts for only 0.1%–0.3% of all kidney tumors and 2%–6% of malignant kidney tumors in children. Accounting for approximately one-third of the total number of cases in children and adolescents with RCC, Xp11.2 tRCC is the most common subtype of the
Kaihang Yang +3 more
doaj +1 more source
Clinical Case Reports, Volume 11, Issue 11, November 2023., 2023 Key Clinical Message Renal cell carcinoma as a secondary malignant neoplasm is relatively rare; however, the possibility of secondary renal cell carcinoma following chemoradiotherapy for childhood nephroblastoma should be considered. Abstract The occurrence of secondary renal cell carcinoma (RCC) following chemoradiotherapy for nephroblastoma is ...
Shunsuke Fujisawa +8 more
wiley +1 more source